Autologous Dendritic Cell Vaccination in Mesothelioma
|2||Active, not recruiting||
Response Evaluation in Malignant Pleural Mesothelioma
|3||Not yet recruiting||
PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma
Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis for Malignant Pleural Effusion Management
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
† Study has passed its completion date and status has not been verified in more than two years.